MannKind Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MannKind Corp.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
/ 
Frequently asked questions
To buy MannKind Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MannKind Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MannKind Corp. is MNKD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MannKind Corp. has its primary listing on NASDAQ. You can trade MannKind Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MannKind Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MannKind Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MannKind Corp..